Strata Critical Medical, Inc.
SRTA
NASDAQ·Healthcare·Medical - Care Facilities·Mkt cap $460.3M
$5.32
▼ -0.93%
P/E
10.65
Mkt Cap
$460.3M
52-Wk Range
$3.85–$6.50
52-Week Range
$3.85 - $6.50
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 33.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
3 reasons
- Exclusive focus on time-critical organ transplant logistics with regulatory expertise
- Integrated air and ground network enabling fastest delivery times
- Mission-critical service with high switching costs and recurring revenue model
Bear Case
1 risk
- High volatility (beta 2.3). Larger-than-normal price swings expected.
Growth
Profitability at risk
Increasing organ transplant demand from aging U.S. population
Value
Deep value opportunity - significant discount to Airlines peers
Momentum
Weak
-8.1% over 3m
Quality
Stable
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying SRTA right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 9, 2026
AUG 4, 2026
Reported EPS of -$0.12 vs -$0.02 consensus (-500.0% surprise). Revenue of $72.5M vs $67.6M expected (+7.2%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-500.0%
Revenue trend · last 8Q
—
+14%
+5%
+4%
-34%
-58%
+24%
+2%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$74.9M
$54.4M
$54.3M
$70.8M
$49.3M
$22.7M
$67.4M
$72.5M
Margins · last 8Q
Gross
21.0%
Operating
-7.5%
Profit
-14.5%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How SRTA stacks vs Medical - Care Facilities
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related